BVES butts heads with colorectal cancer
2011-09-13
(Press-News.org) Once a cancer gains the ability to invade local tissues and spread to a distant site it becomes much harder to treat. A team of researchers, led by Min Chang and Christopher Williams, at Vanderbilt University School of Medicine, Nashville, has now identified the protein BVES as a suppressor of colorectal cancer progression to this dangerous state, leading them to suggest that BVES could be a therapeutic or preventative target in colorectal cancer.
Cancers originating from cells covering any of the external and internal surfaces of the body (epithelial cells) are known as epithelial cancers. If such cancers (e.g., colorectal cancer) are to become invasive and spread to distant sites in the body, some of the epithelial cancer cells must acquire the characteristics of a different cell type, a mesenchymal cell. Protein complexes that link epithelial cells together (junctional complexes) are regulators of epithelial-mesenchymal transition (EMT). Chang, Williams, and colleagues found that the junctional protein BVES regulates EMT in human colon cancer cells. Importantly, the team found that BVES expression was reduced in all stages of human colorectal carcinoma and that restoring BVES expression to normal decreased the in vitro and in vivo cancer cell characteristics of human colon cancer cells. These data provide the rational for the suggestion that targeting BVES could be of benefit to individuals with colorectal cancer.
INFORMATION:
TITLE: BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma
AUTHOR CONTACT:
Min S. Chang
Vanderbilt Eye Institute, Nashville, Tennessee, USA.
Phone: 615.936.6413; Fax: 615.936.6410; E-mail: min.s.chang@vanderbilt.edu.
Christopher S. Williams
Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Phone: 615.322.3642; Fax: 615.343.6229; E-mail: christopher.williams@vanderbilt.edu.
View this article at: http://www.jci.org/articles/view/44228?key=3aac564d108a38a35e37
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-09-13
EDITOR'S PICK: BVES butts heads with colorectal cancer
Once a cancer gains the ability to invade local tissues and spread to a distant site it becomes much harder to treat. A team of researchers, led by Min Chang and Christopher Williams, at Vanderbilt University School of Medicine, Nashville, has now identified the protein BVES as a suppressor of colorectal cancer progression to this dangerous state, leading them to suggest that BVES could be a therapeutic or preventative target in colorectal cancer.
Cancers originating from cells covering any of the external and internal ...
2011-09-13
An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people, according to a study by researchers at the Ernest Gallo Clinic and Research Center, affiliated with the University of California, San Francisco.
Over the course of four weeks, mice genetically engineered to lack the gene for protein kinase C (PKC) epsilon consumed less of a nicotine-containing water solution than normal mice, and were less likely ...
2011-09-13
Lung cancer is one of the most common and deadly types of cancer. Mouse models of lung cancer recapitulate many features of the human disease and have provided new insight about cancer development, progression and treatment. Now, a new study published by Cell Press in the September 13th issue of the journal Cancer Cell identifies protein signatures in mouse blood samples that reflect lung cancer biology in humans. The research may lead to better monitoring of tumor progression as well as blood based early detection strategies for human lung cancer that could have a substantial ...
2011-09-13
African-Americans with prehypertension develop high blood pressure a year sooner than whites, according to research reported in Hypertension: Journal of the American Heart Association.
Blacks with prehypertension also have a 35 percent greater risk of progressing to high blood pressure than whites, according to health records of 18,865 adults 18 to 85.
Prehypertension is blood pressure ranging between 120/80 mm Hg and 139/89 mm Hg. Hypertension is 140/90 mm Hg or higher.
Previous research has shown that coronary heart disease, stroke and high blood pressure are more ...
2011-09-13
Even with the summer beginning to wind down, dental patients from Torrance, CA are finding a new reason to smile this fall. Torrance cosmetic dentist, Dr. Mondavi, and his staff have begun utilizing cutting edge techniques to offer patients the brightest, straightest, and healthiest smiles of their lives.
Many have come to fret and obsess over the appearance of their teeth. A beautiful smile will lead to confidence that will follow an individual around everywhere that they go. On the opposite end of the spectrum, those who feel as if their teeth are not as bright or ...
2011-09-13
Houston, TX – Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center.
The findings, published online in Cancer and updated since first presented at the 2009 Breast Cancer Symposium, could have an impact on how women at highest risk for the disease are counseled and even screened in the future, explained Jennifer Litton, M.D., assistant professor in MD Anderson's ...
2011-09-13
Researchers at USC were surprised recently to discover just how much the rising and setting of the sun drives life on Earth – even in unexpected places.
Their findings, which appear this month in the Proceedings of the National Academy of Sciences, "speak volumes to the evolution of life on Earth," according to USC scientist Andrew Y. Gracey.
"Everything is tied to the rotation of the planet," he said.
In all organisms, a certain amount of gene expression (the process by which products are created from the blueprint contained in genes) is rhythmic. In creatures ...
2011-09-13
Researchers at University Medical Center Utrecht, the Netherlands, have discovered a substance that has an adverse effect on nearly all types of chemotherapy - making cancer cells insensitive to the treatment. Chemotherapy often loses effectiveness over time. It is often unclear how or why this happens.
It now appears that chemotherapy is made ineffective by two types of fatty acid that are made by stem cells in the blood. Under the influence of cisplatin chemotherapy, the stem cells secrete these fatty acids that induce resistance to a broad spectrum of chemotherapies. ...
2011-09-13
EAST LANSING, Mich. --- When countries try to work together to limit the effects of climate change, the fear of being the only nation reducing greenhouse gas emissions – while the others enjoy the benefits with no sacrifice – can bring cooperation to a grinding halt.
In a commentary in the Early Edition of the Proceedings of the National Academy of Sciences, Thomas Dietz, professor of sociology and environmental science and policy and assistant vice president for environmental research at MSU, and Jinhua Zhao, director of the MSU Environmental Science and Policy Program ...
2011-09-13
Researchers from Mount Sinai School of Medicine have for the first time used several imaging techniques to prove the efficacy of a promising new treatment for atherosclerosis—the build-up of plaque in artery walls that can lead to a heart attack. Using positron-emission tomography (PET)/computed tomography (CT) and magnetic resonance imaging (MRI), the research team showed that dalcetrapib, a novel treatment for atherosclerosis, prevented the progression of disease and reduced vascular inflammation over 24 months. The data are published in the September 12 issue of The ...
LAST 30 PRESS RELEASES:
[Press-News.org] BVES butts heads with colorectal cancer
